Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -70.47% is 119% below its 5-year average of -32.12%, around the middle of its 5-year range (-141.43%–4.65%).
5.20% below its 12-month average of -66.99%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -44.28%.
OPERATING MARGIN
-70.47%
OPERATING MARGIN AVG TTM
-66.99%
OPERATING MARGIN AVG 3Y
-41.50%
OPERATING MARGIN AVG 5Y
-32.12%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.20%
CURRENT VS 3Y AVG
-69.81%
CURRENT VS 5Y AVG
-119.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Healthcare Triangle, Inc.
Market Cap
$8.47M
Operating Margin
-70.47%
TTM Avg
-66.99%
3Y Avg
-41.50%
5Y Avg
-32.12%
Market Cap
$8.32M
Operating Margin
-347.91%
TTM Avg
-190.91%
3Y Avg
-98.06%
5Y Avg
-98.06%
Market Cap
$8.14M
Operating Margin
0.00%
TTM Avg
-476.50%
3Y Avg
-901.45%
5Y Avg
-600.97%
Market Cap
$8.01M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.97M
Operating Margin
N/A
TTM Avg
-193400.24%
3Y Avg
-134850.20%
5Y Avg
-97032.76%
Market Cap
$7.95M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.10M
Operating Margin
-986.63%
TTM Avg
-7101.46%
3Y Avg
-3550.73%
5Y Avg
-2367.15%
Market Cap
$7.83M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.47M | -70.47% | -66.99% | -41.50% | -32.12% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.32M | -347.91% | -190.91% | -98.06% | -98.06% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | 0.00% | -476.50% | -901.45% | -600.97% |
| GT Biopharma, Inc. (GTBP)vs › | $8.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $7.97M | N/A | -193400.24% | -134850.20% | -97032.76% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.10M | -986.63% | -7101.46% | -3550.73% | -2367.15% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
18.4%
Operating Margin
-70.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -44.28% |
| 2026-03-31 | -36.76% |
| 2025-12-31 | -141.43% |
| 2025-09-30 | -74.26% |
| 2025-06-30 | -38.20% |
| 2025-03-31 | -37.74% |
| 2024-12-31 | -38.90% |
| 2024-09-30 | -48.36% |
| 2024-06-30 | -46.18% |
| 2024-03-31 | -41.57% |
| 2023-12-31 | -6.78% |
| 2023-09-30 | -19.59% |
| 2023-06-30 | -18.71% |
| 2023-03-31 | -32.62% |
| 2022-12-31 | -55.82% |
| 2022-09-30 | -18.80% |
| 2022-06-30 | -12.37% |
| 2022-03-31 | -17.85% |
| 2021-12-31 | -36.35% |
| 2021-09-30 | -21.92% |
| 2021-06-30 | 4.65% |
| 2020-09-30 | 2.60% |
| 2020-06-30 | 1.86% |
